Sulfonylurea Receptor 1 in Central Nervous System Injury: A Focused Review
Open Access
- 20 June 2012
- journal article
- review article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 32 (9), 1699-1717
- https://doi.org/10.1038/jcbfm.2012.91
Abstract
The sulfonylurea receptor 1 (Sur1)-regulated NCCa-ATP channel is a nonselective cation channel that is regulated by intracellular calcium and adenosine triphosphate. The channel is not constitutively expressed, but is transcriptionally upregulated de novo in all cells of the neurovascular unit, in many forms of central nervous system (CNS) injury, including cerebral ischemia, traumatic brain injury (TBI), spinal cord injury (SCI), and subarachnoid hemorrhage (SAH). The channel is linked to microvascular dysfunction that manifests as edema formation and delayed secondary hemorrhage. Also implicated in oncotic cell swelling and oncotic (necrotic) cell death, the channel is a major molecular mechanism of ‘accidental necrotic cell death’ in the CNS. In animal models of SCI, pharmacological inhibition of Sur1 by glibenclamide, as well as gene suppression of Abcc8, prevents delayed capillary fragmentation and tissue necrosis. In models of stroke and TBI, glibenclamide ameliorates edema, secondary hemorrhage, and tissue damage. In a model of SAH, glibenclamide attenuates the inflammatory response due to extravasated blood. Clinical trials of an intravenous formulation of glibenclamide in TBI and stroke underscore the importance of recent advances in understanding the role of the Sur1-regulated NCCa-ATP channel in acute ischemic, traumatic, and inflammatory injury to the CNS.Keywords
This publication has 103 references indexed in Scilit:
- Integrins as receptor targets for neurological disordersPharmacology & Therapeutics, 2012
- Glibenclamide—10-h Treatment Window in a Clinically Relevant Model of StrokeTranslational Stroke Research, 2012
- Spinal cord injury with unilateral versus bilateral primary hemorrhage — Effects of glibenclamideExperimental Neurology, 2012
- Independent evaluation of the effects of glibenclamide on reducing progressive hemorrhagic necrosis after cervical spinal cord injuryExperimental Neurology, 2012
- Comparative effects of glibenclamide and riluzole in a rat model of severe cervical spinal cord injuryExperimental Neurology, 2012
- Metamorphosis of Subarachnoid Hemorrhage Research: from Delayed Vasospasm to Early Brain InjuryMolecular Neurobiology, 2010
- Unfractionated Heparin: Multitargeted Therapy for Delayed Neurological Deficits Induced by Subarachnoid HemorrhageNeurocritical Care, 2010
- HIF-1α inhibition ameliorates neonatal brain injury in a rat pup hypoxic–ischemic modelNeurobiology of Disease, 2008
- Drugs acting on SUR1 to treat CNS ischemia and traumaCurrent Opinion in Pharmacology, 2008
- Non-selective cation channels, transient receptor potential channels and ischemic strokeBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007